Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Gecacitinib in the Treatment of Steroid-Refractory/Dependent Chronic Graf Versus Host Disease (cGVHD).	HSCT; cGVHD	Not yet recruiting	Phase 1 / Phase 2	2026-03-17		NCT07476872

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institute of Hematology & Blood Diseases Hospital, China	285

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials